The content addresses the increasing role of quantitative and functional imaging in medical trials and the development of new therapeutics multidisciplinary clinical trial teams will enjoy the readily comprehensible information carefully selected didactic elements and excellent quality of illustrations reviewed by peter reimer prof dr med. Medical imaging is a key asset in the drug development process as it can provide efficacy evaluation and safety monitoring data needed in clinical trials for regulatory submission in addition imaging provides insights on the drug mechanism of action moa and drug effects that can help researchers take scientifically sounded decisions. Medical imaging in clinical trials is a key text in understanding the methodology and the metrics that are required in the field of medical imagingas the pharmaceutical biotech and medical device industries continue to identify ways to improve and speed up product development medical imaging plays a more significant role. In the last few years the use of medical imaging has increased exponentially in routine clinical practice this has been reflected in a rapidly increasing use of medical imaging in clinical trials through all phases more recently this has culminated in a number of inter disciplinary meetings with the various stake holders including the fda